Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Saved in:
Bibliographic Details
Title: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.
Authors: Visentin A; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy., Gaffo E; Department of Molecular Medicine, University of Padua, Padova, Italy., Fürstenau M; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Rogers KA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Panagiotis B; Department of Immunology, Genetics and Pathology & Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Cui C; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Tianjin Institutes of Health Science, Tianjin, China., Miller C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Plevova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic., Oscier D; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Davis Z; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Nguyen-Khac F; Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris, France., Roncaglia E; Computational Genomics Group, Department of Oncology, Surgery and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy., Rigolin GM; Hematology Section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy., Athanasiadou A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Baran-Marszak F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Valiente A; Servicio de Genética. Hospital Universitario de Navarra, Pamplona, Spain., Terol MJ; Servicio de Hematología y Oncología Médica, Hospital Clinico Universitario de Valencia, Valencia, Spain., Abrisqueta P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain., Martines A; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy., Bonaldi L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy., Mauro FR; Department of Translational and Precision Medicine, Hematology unit, 'Sapienza' University, Rome, Italy., Scarfò L; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy., Chatzikonstantinou T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Tausch E; Ulm University, Ulm, Germany., Kreuzer KA; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Kater A; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, The Netherlands, Amsterdam, Netherlands., Bosch F; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Doubek M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic., Panagiotidis P; First Department of Propaedeutic, University of Athens, Athens, Greece., Kalashnikova O; Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russian Federation., Frezzato F; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy., Calabretto G; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy., Ruocco V; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy., Orsi S; Department of Molecular Medicine, University of Padua, Padova, Italy., Cellini A; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy., Angotzi F; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy., Serafin A; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy., Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Tianjin Institutes of Health Science, Tianjin, China., Eichhorst B; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Cuneo A; Hematology Section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy., Ghia P; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Trentin L; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy. livio.trentin@unipd.it., Bortoluzzi S; Computational Genomics Group, Department of Oncology, Surgery and Gastroenterology, University of Padua, Padova, Italy. stefania.bortoluzzi@unipd.it.
Source: Leukemia [Leukemia] 2025 Dec; Vol. 39 (12), pp. 2957-2967. Date of Electronic Publication: 2025 Sep 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-025-02755-8